Evaluating A-CRA for Youth in Institutional Care
The Effectiveness of A-CRA in Compulsory Institutional Care for Youth - an Independent Randomized Controlled Trial
This study is testing a new approach called A-CRA to see if it can help young people in locked care facilities overcome substance use problems and improve their behavior.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 220 (estimated) |
| Ages | 16 Years to 21 Years |
| Sex | All |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 4 sites (Fagersta, Västmanland and 3 other locations) |
| Trial ID | NCT06094972 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Adolescent Community Reinforcement Approach (A-CRA) for youth aged 16-21 who are placed in compulsory institutional care due to substance use disorders and socially disruptive behavior. A-CRA is designed to promote long-term abstinence and improve social stability while addressing co-morbid psychiatric issues. The study aims to assess both short- and long-term effects of A-CRA on substance use and behavioral problems in this vulnerable population. Given the unique challenges of institutional settings, this research seeks to adapt and implement A-CRA in a way that is effective for youth in locked care environments.
Who should consider this trial
Good fit: Ideal candidates for this study are youth aged 16-21 who are currently placed in institutional care and are struggling with substance use disorders and socially disruptive behaviors.
Not a fit: Patients with severe cognitive or psychiatric conditions that prevent them from providing informed consent or undergoing assessment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for youth with substance use disorders in institutional settings, leading to better long-term social and emotional stability.
How similar studies have performed: While A-CRA has shown effectiveness in outpatient settings, this study represents a novel approach as it adapts the intervention for use in compulsory institutional care, which has not been extensively evaluated before.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 16-21 * Placed in institutional care * Suffers from SUD and socially disruptive behaviour * Ability to read and understand informed consent and interventions Exclusion Criteria: * Severe cognitive or psychiatric condition preventing the ability to provide informed consent or undergo assessment or interventions * Serious somatic condition requiring acute medical attention
Where this trial is running
Fagersta, Västmanland and 3 other locations
- Sundbo — Fagersta, Västmanland, Sweden (Recruiting)
- Fagersta — Lindome, Västra Götaland, Sweden (Recruiting)
- Statens institutionsstyrelse, SiS, Johannisberg — Kalix, Sweden (Recruiting)
- Statens institutionsstyrelse, SiS, Ljungbacken — Uddevalla, Sweden (Recruiting)
Study contacts
- Principal investigator: Tobias Lundgren, PhD — Karolinska Institutet
- Study coordinator: Tobias Lundgren, PhD
- Email: tobias.lundgren@ki.se
- Phone: 070-612 45 55
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.